Kim Kardashian was admonished by the Food and Drug Administration last week for promoting a morning sickness drug on Instagram. IZEA CEO Ted Murphy explains what celebs and brands need to consider when they make these social transactions, as well as why it’s so important to disclose these transactions and meet FTC standards.
Kim Kardashian’s Instagram Blunder a Valuable Lesson for Web Influencers
You May Also Like
The $43 Billion Shift: How CMOs Scale Creator Marketing
The $43 Billion Shift: How CMOs Scale Creator Marketing
The market is shifting rapidly, and you feel the growing gap. Your internal teams are executing disjointed creator campaigns. They deliver fragmented reports that fail…
John FrancisMay 21, 2026
How Creators are Rewriting the Summer Movie Playbook
How Creators are Rewriting the Summer Movie Playbook
Learn how studios are shifting from traditional ads to creator-led marketing. Discover how franchise lore and influencers drive summer box office success.
John FrancisApril 30, 2026
The CMO’s Guide to Scaling Creator Strategy: In-House vs. Agency
The CMO’s Guide to Scaling Creator Strategy: In-House vs. Agency
Should enterprise brands build an in-house creator team or hire an influencer marketing agency? Learn why the lean hybrid model is the ultimate solution.
John FrancisApril 28, 2026
